Use of a new, low-pH immunoglobulin G preparation during episodes of bacteremia in the rat.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3092308)

Published in Rev Infect Dis on October 16, 1986

Authors

T E Emerson, M S Collins, M D Budinger

Articles by these authors

(truncated to the top 100)

Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother (1979) 3.79

The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. J Immunol (1992) 1.92

Safety, pharmacokinetics, and functional activity of human anti-Pseudomonas aeruginosa monoclonal antibodies in septic and nonseptic patients. J Infect Dis (1991) 1.50

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med (1987) 1.48

Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circ Shock (1990) 1.39

Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis. Infect Immun (1990) 1.38

Characterisation of an antigenically unusual virus responsible for two outbreaks of Newcastle disease in the Republic of Ireland in 1990. Vet Rec (1992) 1.35

Inhibition by lysozyme of growth of the spherule phase of Coccidioides immitis in vitro. Infect Immun (1974) 1.33

Protective activity of an intravenous immune globulin (human) enriched in antibody against lipopolysaccharide antigens of Pseudomonas aeruginosa. Am J Med (1984) 1.31

Characterization of viruses which represent further distinct serotypes (PMV-8 and PMV-9) of avian paramyxoviruses. Arch Virol (1983) 1.25

Inhibition of growth of Coccidioides immitis on Sabouraud medium containing polymyxin B. J Clin Microbiol (1975) 1.22

Comparison of Newcastle disease viruses isolated from cormorants in Canada and the USA in 1975, 1990 and 1992. Can J Vet Res (1996) 1.18

Antigenic diversity and similarities detected in avian paramyxovirus type 1 (Newcastle disease virus) isolates using monoclonal antibodies. Avian Pathol (1997) 1.17

Immunization of mice against coccidioidomycosis with a subcellular vaccine. Infect Immun (1979) 1.16

Effect of amphotericin B and rifampin against Coccidioides immitis in vitro and in vivo. Antimicrob Agents Chemother (1976) 1.16

Isolation and properties of viruses from poultry in Hong Kong which represent a new (sixth) distinct group of avian paramyxoviruses. J Gen Virol (1980) 1.15

Location of neutralizing epitopes on the fusion protein of Newcastle disease virus strain Beaudette C. J Gen Virol (1989) 1.12

Antithrombin-III prevents the lethal effects of Escherichia coli infusion in baboons. Circ Shock (1988) 1.11

Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med (1984) 1.10

Widespread occurrence of Pneumocystis carinii in commercial rat colonies detected using targeted PCR and oral swabs. J Clin Microbiol (2001) 1.09

Cutaneous infection in man caused by Fusarium moniliforme. Sabouraudia (1977) 1.08

Inhibitors of sterol biosynthesis and amphotericin B reduce the viability of pneumocystis carinii f. sp. carinii. Antimicrob Agents Chemother (2000) 1.04

Astrovirus-like particles associated with hepatitis in ducklings. Vet Rec (1984) 1.03

Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma (1992) 1.00

Cardiovascular responses of the primate in endotoxin shock. Am J Physiol (1966) 1.00

Pathogenicity of PMV-3/parakeet/Netherlands/449/75 for chickens. Avian Pathol (1982) 0.99

Anti-Pseudomonas aeruginosa activity of an intravenous human IgG preparation in burned mice. J Trauma (1983) 0.95

Antigenic and genetic characterisation of Newcastle disease viruses isolated from outbreaks in domestic fowl and turkeys in Great Britain during 1997. Vet Rec (1999) 0.93

Lysozyme-enhanced killing of Candida albicans and Coccidioides immitis by amphoteracin B. Sabouraudia (1974) 0.93

Avian infectious bronchitis virus structural polypeptides: effect of different conditions of disruption and comparison of different strains and isolates. Arch Virol (1980) 0.93

Uniform susceptibility of various strains of Coccidioides immitis to amphotericin B. Antimicrob Agents Chemother (1977) 0.92

Paramyxovirus type 1 infections of racing pigeons: 1 characterisation of isolated viruses. Vet Rec (1984) 0.90

Rapid pathotyping of Newcastle disease virus (NDV) using fluorogenic probes in a PCR assay. Vet Microbiol (2001) 0.90

Monoclonal antibody-mediated protection and neutralization of motility in experimental Proteus mirabilis infection. Infect Immun (1989) 0.89

Protection against disseminated intravascular coagulation and death by antithrombin-III in the Escherichia coli endotoxemic rat. Circ Shock (1987) 0.88

Pseudomonas hyperimmune globulin passive immunotherapy for pulmonary exacerbations in cystic fibrosis. Pediatr Pulmonol (1990) 0.88

Treatment of experimental Pseudomonas aeruginosa pneumonia with a human IgM monoclonal antibody. J Infect Dis (1989) 0.87

Intravenous immunoglobulin for modification of cytomegalovirus infections associated with bone marrow transplantation. Preliminary results of a controlled trial. Am J Med (1984) 0.87

Early acquisition of Pneumocystis carinii in neonatal rats using targeted PCR and oral swabs. J Eukaryot Microbiol (2001) 0.86

Effect of pH on the growth and cytopathogenicity of avian infectious bronchitis virus in chick kidney cells. Arch Virol (1975) 0.86

Integrative research review of risk behaviors among adolescents in rural, suburban, and urban areas. J Adolesc Health (1999) 0.86

Antithrombin-III treatment limits disseminated intravascular coagulation in endotoxemia. Circ Shock (1989) 0.86

Effects of prostaglandin E1 and F2 alpha on venous return and other parameters in the dog. Am J Physiol (1971) 0.85

Antigenic and structural relationships between avian paramyxoviruses isolated from ducks in Hong Kong and Mississippi, U.S.A. J Gen Virol (1979) 0.84

Further characterisation of a virus associated with turkey rhinotracheitis. Vet Rec (1986) 0.83

Characterization of viruses from doves representing a new serotype of avian paramyxoviruses. Arch Virol (1981) 0.83

Involvement of adenosine in cerebral hypoxic hyperemia in the dog. Am J Physiol (1981) 0.83

Properties of a newly isolated, serologically distinct avian paramyxovirus. Arch Virol (1979) 0.82

Characterisation of avian paramyxoviruses of serotype PMV-3 isolated from commercial turkeys in Great Britain. Avian Pathol (1984) 0.82

Development of a real-time reverse-transcription PCR for the detection and simultaneous pathotyping of Newcastle disease virus isolates using a novel probe. Arch Virol (2009) 0.82

Comparison of varicella zoster antibody titers in patients given intravenous immune serum globulin or varicella zoster immune globulin. J Pediatr (1984) 0.82

Identification of paramyxoviruses isolated from birds dying in quarantine in Great Britain during 1980 to 1981. Vet Rec (1982) 0.81

Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice. Infect Immun (1984) 0.81

Synergistic protection from lung damage by combining antithrombin-III and alpha 1-proteinase inhibitor in the E. coli endotoxemic sheep pulmonary dysfunction model. Circ Shock (1988) 0.81

Heterogeneity of infectious bronchitis virus grown in eggs. Arch Virol (1976) 0.81

Comparative in vivo activity between intravenous immune globulin prepared by reduction and alkylation or by low pH. J Infect Dis (1985) 0.81

Characterization of paramyxoviruses isolated from penguins in Antarctica and sub-Antarctica during 1976-1979. Arch Virol (1989) 0.81

Use of monoclonal antibodies in the characterisation of avian paramyxovirus type 1 (Newcastle disease virus) isolates submitted to an international reference laboratory. Avian Pathol (1987) 0.81

Experimental infection of turkeys, chickens, ducks, geese, guinea fowl, pheasants and pigeons with turkey rhinotracheitis virus. Vet Rec (1988) 0.80

Antibodies to TRT in chickens with swollen head syndrome. Vet Rec (1987) 0.80

Comparative anti-Pseudomonas aeruginosa activity of chemically modified and native immunoglobulin G (human), and potentiation of antibiotic protection against Pseudomonas aeruginosa and group B Streptococcus in vivo. Am J Med (1984) 0.80

Paragonimus westermani: a cause of cavitary lung disease in an Indochinese refugee. South Med J (1981) 0.80

The polypeptide composition of isolated surface projections of avian infectious bronchitis virus. J Gen Virol (1980) 0.80

Participation of endogenous vasoactive agents in the pathogenesis of endotoxin shock. Adv Exp Med Biol (1971) 0.80

[Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model]. Infection (1987) 0.80

Skeletal muscle insulin resistance during Escherichia coli bacteremic shock in the dog. Surgery (1981) 0.79

Enzyme replacement for lactose malabsorption using a beta-D-galactosidase. J Clin Gastroenterol (1989) 0.79

Experimental assessment of the pathogenicity of the Newcastle disease viruses from outbreaks in Great Britain in 1997 for chickens and turkeys, and the protection afforded by vaccination. Avian Pathol (1999) 0.79

Effects of fibronectin pretreatment on cardiovascular, acid-base, metabolic, and organ function indices during endotoxin shock in the dog. Circ Shock (1986) 0.79

Effects of acetylcholine, histamine, and serotonin infusion on venous return in dogs. Am J Physiol (1968) 0.79

Effects of angiotensin, epinephrine, norepinephrine, and vasopressin on venous return. Am J Physiol (1966) 0.79

Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ Shock (1991) 0.79

Changes of venous return and other hemodynamic parameters during bradykinin infusion. Am J Physiol (1967) 0.78

Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation. Circ Shock (1988) 0.78

Rapid pathotyping of Newcastle disease virus using a single-chain Fv displayed on phage against the C-terminal end of the F2 polypeptide. Arch Virol (2002) 0.78

Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin. Am J Med (1984) 0.78

Cerebral hemodynamics, vascular reactivity, and metabolism during canine endotoxin shock. Circ Shock (1977) 0.78

Methylprednisolone in the prevention of cerebral hemodynamic and metabolic disorders during endotoxin shock in the dog. Surg Gynecol Obstet (1979) 0.78

Treatment of murine coccidioidomycosis with polymyxin B. Antimicrob Agents Chemother (1976) 0.78

A simple technique which maintains vascular patency after catheterization. Lab Anim Sci (1990) 0.78

Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25. Vox Sang (1991) 0.78

The structural polypeptides of avian paramyxoviruses. Arch Virol (1981) 0.78

Viruses and virus-like particles detected in samples from diseased game birds in Great Britain during 1988. Avian Pathol (1990) 0.77

Blood flow in seven regions of the brain during endotoxin shock in the dog. Proc Soc Exp Biol Med (1977) 0.77

Isolation and characterisation of a parvovirus from goslings. Vet Rec (1981) 0.77

Direct effects of gram-negative endotoxin on skeletal muscle glucose uptake. Am J Physiol (1981) 0.77

Endotoxin shock in chronic splanchnic denervated dogs. J Trauma (1965) 0.77

Effects of slow intravenous endotoxin infusion on hemodynamics and survival in dogs. J Appl Physiol (1967) 0.77

Routine virus isolation or detection in the diagnosis of diseases in birds. Avian Pathol (1988) 0.77

Isolation of an enterovirus-like agent from the meconium of dead-in-shell chicken embryos. Vet Rec (1984) 0.77

[Use of a polyvalent intravenous immunoglobulin or specific cytomegalovirus hyperimmunoglobulin for modification of cytomegalovirus infections and prevention of interstitial pneumonias following bone marrow transplantation]. Immun Infekt (1985) 0.76

In situ kidney pressure-flow-resistance relationship during endotoxin shock in dogs. Proc Soc Exp Biol Med (1966) 0.76

Partial characterisation of five cloned viruses differing in pathogenicity, obtained from a single isolate of pigeon paramyxovirus type 1 (PPMV-1) following passage in fowls' eggs. Arch Virol (2007) 0.76

Insulin-like action of E. coli endotoxin in promoting skeletal muscle glucose uptake in the dog. Adv Shock Res (1981) 0.76

Effects of naloxone therapy on hemodynamics and metabolism following a superlethal dosage of Escherichia coli endotoxin in dogs. Surg Gynecol Obstet (1981) 0.76

Direct effects of insulin and endotoxin on glucose uptake by skeletal muscle during high cardiac index sepsis in the dog. Surg Gynecol Obstet (1982) 0.76

Isolation of a chicken embryo-lethal rotavirus from a lovebird (Agapornis species). Vet Rec (1988) 0.76

Transmission of hepatitis after the administration of intravenous immunoglobulins. Am J Clin Pathol (1993) 0.76

Splanchnic sympathetic and adrenal participtation in endotoxin shock. J Okla State Med Assoc (1966) 0.76

Evaluation of relationships between avian paramyxoviruses isolated from birds of the family Columbidae. Arch Virol (1991) 0.76